FDA approves new obesity drug from Eli Lilly named Zepbound
The Food and Drug Administration on Wednesday approved Eli Lilly’s diabetes drug for treating obesity, opening the door for ...
Forbes10mon
FDA Approved A New Weight Loss Drug Zepbound. Here’s What To Know And Expect
The FDA recently approved Zepbound, a weekly injectable drug targeted to treat obesity. The medication contains tirzepatide, the same active ingredient that is also present in the diabetes drug ...
Daily Mail26d
Free anti-obesity drug is approved
A controversial anti-obesity drug is set to become more widely available on the NHS. Orlistat, otherwise known as Xenical, has been prescribed free to some obese patients for the past two years.
pharmaphorum2d
FDA approves PureTech's obesity device Plenity
The FDA has approved PureTech Health’s ‘space ... the pharmaceutical company whose products have emerged as the biggest selling anti-obesity drugs. In contrast, PureTech said Plenity is ...
Verywell Health on MSN3mon
Anti-Obesity Drug Zepbound May Help Treat Some Forms of Sleep Apnea
the latest and most potent injectable anti-obesity medication approved by the FDA, may be an effective treatment for certain ...
Outsourcing-pharma3d
Antag Therapeutics gets FDA clearance to start clinical trials with new obesity drug
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
Medscape2y
Pharmacotherapy for Obesity
In this article, we provide an overview of currently available anti-obesity agents ... interventions to treat obesity. Despite these high demands for new drug approval, the market for a safe ...
Diversified Exposure To The Weight Loss Drug Market
The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...
tyla6d
What Ozempic actually does to your body as numerous celebrities speak out about drug
More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...
Benefits Pro17d
Employer plans face GLP-1 anti-obesity drug rebate threats
Sanders, but Novo CEO blames PBMs for high Wegovy prices About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be about $10,000 ...
Business Insider India3y
A potential 'game changer' drug for weight loss and obesity was just approved by the FDA
The US Food and Drug Administration has approved a drug that could help with chronic weight management in people who are obese and overweight, the agency said in a press release on Friday.
WebMD26d
FDA Approves First Injectable Version of Cancer Drug
The approval marks Tecentriq Hybreza as the first anti-PD-(L)-1 cancer immunotherapy drug available as a subcutaneous injection. The injectable form of the cancer immunotherapy drug "offers ...